IGC Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THC - IGC Pharma, INC.

Press

Releases

June 22, 2021

IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC

Related Posts

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

May 12, 2025

IGC Pharma Welcomes Strategic Investment from Advisors

April 24, 2025

IGC Pharma Welcomes Industry Leaders to Advisory Board, Supporting Alzheimer’s Innovation and AI-Driven Programs

April 21, 2025

CEO Update

IGC Pharma Presents Genetic Toxicology Safety Data on API in IGC-AD1, at the 2025 Genetic Toxicology Association Meeting

May 12, 2025

IGC Pharma Welcomes Strategic Investment from Advisors

April 24, 2025